ADC-1012

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameADC-1012
Drug Alias NameIL-23 antagonist (Alligator Bioscience)ADC-1012
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionInterleukin-23 inhibitors
TargetsInterleukin-23
Therapy Area/IndicationsInflammationNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAlligator Bioscience Ab
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAlligator Bioscience Ab
Active IndicationsN/A
Inactive IndicationsInflammationNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A